Fresenius Kabi USA announced today that it initiated the voluntary recall of seven lots of its sodium acetate injection.
Lake Zurich, Illinois-based Fresenius Kabi recalled the USP, 400 mEq/100 mL (4 mEq/mL), 100 mL fill in a 100 mL vial to the user level due to the presence of particulate matter found in reserve and/or stability sample vials.
Get the full story at our sister site, Drug Delivery Business News.